These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33662596)

  • 41. Diagnostic performance of Liver Imaging Reporting and Data System treatment response algorithm: a systematic review and meta-analysis.
    Youn SY; Kim DH; Choi SH; Kim B; Choi JI; Shin YR; Oh SN; Rha SE
    Eur Radiol; 2021 Jul; 31(7):4785-4793. PubMed ID: 33409795
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inter-reader agreement of abbreviated magnetic resonance imaging for hepatocellular carcinoma detection: a systematic review and meta-analysis.
    Kim DH; Choi SH; Lee JS; Choi JI
    Abdom Radiol (NY); 2022 Jan; 47(1):123-132. PubMed ID: 34633497
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of LI-RADS 2018 and KLCA-NCC 2018 for noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging.
    Lee S; Kim SS; Chang DR; Kim H; Kim MJ
    Clin Mol Hepatol; 2020 Jul; 26(3):340-351. PubMed ID: 32492765
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is 3-Tesla Gd-EOB-DTPA-enhanced MRI with diffusion-weighted imaging superior to 64-slice contrast-enhanced CT for the diagnosis of hepatocellular carcinoma?
    Maiwald B; Lobsien D; Kahn T; Stumpp P
    PLoS One; 2014; 9(11):e111935. PubMed ID: 25375778
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overall diagnostic accuracy of different MR imaging sequences for detection of dysplastic nodules: a systematic review and meta-analysis.
    Xiong J; Luo J; Bian J; Wu J
    Eur Radiol; 2022 Feb; 32(2):1285-1296. PubMed ID: 34357448
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of LR-5 and LR-4/5 by Liver Imaging Reporting and Data System (MRI) for hepatocellular carcinoma: A meta-analysis.
    Jin H; Huang J; Zhang M; Yang Y; Huang H; Feng X; Long B; Huang L; Zeng Y
    Asian J Surg; 2023 Jan; 46(1):82-88. PubMed ID: 35431127
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravoxel incoherent motion diffusion-weighted imaging of hepatocellular carcinoma: Is there a correlation with flow and perfusion metrics obtained with dynamic contrast-enhanced MRI?
    Hectors SJ; Wagner M; Besa C; Bane O; Dyvorne HA; Fiel MI; Zhu H; Donovan M; Taouli B
    J Magn Reson Imaging; 2016 Oct; 44(4):856-64. PubMed ID: 26919327
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diffusion-weighted imaging of the liver in patients with chronic liver disease: comparison of monopolar and bipolar diffusion gradients for image quality and lesion detection.
    Lewis S; Kamath A; Chatterji M; Patel A; Shyknevsky I; Dyvorne HA; Kuehn B; Taouli B
    AJR Am J Roentgenol; 2015 Jan; 204(1):59-68. PubMed ID: 25539238
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extracellular contrast-enhanced MRI with diffusion-weighted imaging for HCC diagnosis: prospective comparison with gadoxetic acid using LI-RADS.
    Cha DI; Choi GS; Kim YK; Kim JM; Kang TW; Song KD; Ahn SH
    Eur Radiol; 2020 Jul; 30(7):3723-3734. PubMed ID: 32128620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic Performance of 2018 KLCA-NCC Practice Guideline for Hepatocellular Carcinoma on Gadoxetic Acid-Enhanced MRI in Patients with Chronic Hepatitis B or Cirrhosis: Comparison with LI-RADS Version 2018.
    Lee SM; Lee JM; Ahn SJ; Kang HJ; Yang HK; Yoon JH
    Korean J Radiol; 2021 Jul; 22(7):1066-1076. PubMed ID: 33739633
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of diffusion-weighted imaging and T2-weighted single shot fast spin-echo: Implications for LI-RADS characterization of hepatocellular carcinoma.
    Hicks RM; Yee J; Ohliger MA; Weinstein S; Kao J; Ikram NS; Hope TA
    Magn Reson Imaging; 2016 Sep; 34(7):915-21. PubMed ID: 27108359
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial.
    An C; Kim DY; Choi JY; Han KH; Roh YH; Kim MJ
    BMC Cancer; 2018 Sep; 18(1):915. PubMed ID: 30249190
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High-flow haemangiomas versus hypervascular hepatocellular carcinoma showing "pseudo-washout" on gadoxetic acid-enhanced hepatic MRI: value of diffusion-weighted imaging in the differential diagnosis of small lesions.
    Nam SJ; Yu JS; Cho ES; Kim JH; Chung JJ
    Clin Radiol; 2017 Mar; 72(3):247-254. PubMed ID: 27789027
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of hepatocellular carcinoma (HCC) using super paramagnetic iron oxide (SPIO)-enhanced MRI: Added value of diffusion-weighted imaging (DWI).
    Nishie A; Tajima T; Ishigami K; Ushijima Y; Okamoto D; Hirakawa M; Nishihara Y; Taketomi A; Hatakenaka M; Irie H; Yoshimitsu K; Honda H
    J Magn Reson Imaging; 2010 Feb; 31(2):373-82. PubMed ID: 20099351
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of noncontrast, dynamic, and hepatobiliary phase abbreviated MRI protocols for detection of hepatic malignancies.
    Lee JH; Kim YK; Min JH; Cha D; Hwang JA; Ahn S
    Clin Imaging; 2023 Sep; 101():206-214. PubMed ID: 37421716
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypervascular hepatocellular carcinoma in the cirrhotic liver: diffusion-weighted imaging versus superparamagnetic iron oxide-enhanced MRI.
    Chung J; Yu JS; Kim DJ; Chung JJ; Kim JH; Kim KW
    Magn Reson Imaging; 2011 Nov; 29(9):1235-43. PubMed ID: 21907517
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic performance of a minimized protocol of non-contrast MRI for hepatocellular carcinoma surveillance.
    Kim JS; Lee JK; Baek SY; Yun HI
    Abdom Radiol (NY); 2020 Jan; 45(1):211-219. PubMed ID: 31650374
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic Review.
    van der Pol CB; Lim CS; Sirlin CB; McGrath TA; Salameh JP; Bashir MR; Tang A; Singal AG; Costa AF; Fowler K; McInnes MDF
    Gastroenterology; 2019 Mar; 156(4):976-986. PubMed ID: 30445016
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
    Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
    J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.